News and Views

Using Standards Balances Technology Advancements With Critical Thinking

Advancements in medical records technology provide safeguards and contribute to overall patient safety. However, consider the following treatment scenarios and how they may present opportunities for error and jeopardize patient safety.

Trending Topics

View All Topics

Chemotherapy administration safeety

Who Is Monitoring Your Infusions for Administration Safety?

Immunotherapy Communication

Patient-Provider Communication on Immunotherapy Can Be Improved

Immunotherapy Inquiry

The Case of the Immunotherapy Inquiry, Part II

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves Neratinib for Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer

Susan Schneider

Through Early Detection, We Can Impact Cancer Mortality

Massage therapy

Patient Quality of Life

Massage Has Therapeutic Value for Patients With Cancer

Cancer Immunotherapy

ONS Answers Your Top Questions About Cancer Immunotherapy

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Grants Regular Approval to Blinatumomab and Expands Indication to Include Philadelphia Chromosome-Positive B Cell ALL

USP <800>

What Oncology Nurses Need to Know About USP <800>

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves L-Glutamine Powder for the Treatment of Sickle Cell Disease

IM Injection of Fulvestrant

Sponsored Content

Best Practices for IM Injection of Fulvestrant

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves First Single NGS Test to Detect Multiple RAS Mutations

Nutritional and Physical Activity Guidelines

American Cancer Society (ACS)

Adherence to Nutritional and Physical Activity Guidelines Improves Survival in Patients With Colon Cancer

Oncology and ICU Nurses Working Together

Interprofessional Teams

How Can Oncology and ICU Nurses Work Together to Treat Critically Ill Patients With Cancer?

Critical Care for Patients With Cancer

Clinical Practice

Critical Care for Patients With Cancer

Prostate Cancer Risk

Cancer Research

Less Sleep May Increase Risk of Death From Prostate Cancer

Safe handling immunotherapy

What Safe Handling and Administration Requirements Apply to Immunotherapy?

NCI Is Training the Future Cancer Research Workforce

National Cancer Institute (NCI)

How NCI Is Training the Future Cancer Research Workforce

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves Betrixaban for Extended Duration Prophylaxis of Venous Thromboembolism

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves Dabrafenib and Trametinib Combination for Metastatic NSCLC with BRAF V600E Mutation

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves Rituximab Plus Hyaluronidase Combination for Treatment of FL, DLBCL, and CLL

Combination therapies

Combination Treatment Improves Survival for Advanced Melanoma

FDA Approvals for Targeted and Immuno-Oncology

U.S. Food and Drug Administration (FDA)

Recent FDA Approvals Continue to Focus on Targeted and Immunotherapy

CancerLinQ

Clinical Practice

How ONS and Oncology Nursing Are Helping to Define Big Data and Cancer Care

BRCA Testing

Genetics & Genomics

More Women Undergo BRCA Testing, but Not High-Risk Patients

Substance Abuse and Addiction

Pain Management

Managing Pain in Patients With Substance Use Disorder

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves ALA Optical Imaging Agent for Gliomas

ONS Leadership

Members Meet to Lead ONS Into the Future

Acupuncture in Treating Hot Flashes

Clinical Practice

The Role of Acupuncture in Treating Hot Flashes in Breast Cancer Survivors

DNA Copying Causes Most Cancer Mutations

Cancer Research

Random DNA Copying Causes Most Cancer Mutations

Pam Ginex

Cultivate Your Immunotherapy Education With ONS Resources

immunotherapy for cancer treatment

How the Evolution of Immunotherapy Will Impact Oncology Nurses

Multi-Drug Resistant Fungus

CDC Warns Healthcare Workers of Emerging, Multidrug-Resistant Fungus

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Broadens Ceritinib Indication to Previously Untreated ALK-Positive Metastatic NSCLC

CAR T-Cell Immunotherapy

Cancer Research

Gene-Editing Tool May Better Deliver CAR T-Cell Immunotherapy

Accelerated Approval to Pembrolizumab

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Pembrolizumab for First Tissue/Site Agnostic Indication

Recognize and Release Muscle Tension

Nurse Well-Being

Learn to Recognize and Release Muscle Tension

administering IV chemotherapy treatments

What Special Considerations Are Needed When Setting up IV Chemotherapy?

Chemical Coping

Pain Management

When Ineffective Pain Control Means Chemical Coping

Telehealth

Clinical Practice Guidelines

Joint Commission Offers Telehealth Revisions to Hospital, Ambulatory Accreditation Standards

Oncology Nurse Navigator

Nurse Navigator

Updated Competencies Outline Oncology Nurse Navigator Role From Novice to Expert

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Grants Approval to Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma

Seborrheic Keratosis

Dermascopic Clues Help Identify Seborrheic Keratosis-Like Melanoma

Caring for Multiple Patients

Clinical Practice

The Challenge of Caring for Multiple Patients With Cancer

Cancer Clinical Trials

Oncology Clinical Trials

How One Institution Improved Accrual to Cancer Clinical Trials

Opioids

Pain Management

The Case of the Omitted Opioid

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Pembrolizumab in Combination With Pemetrexed and Carboplatin for Treatment of Metastatic Non-Squamous NSCLC

Celebrate Nurses

Renew Your Mind, Body, and Spirit This May While Celebrating Nurses

Melanoma Survivors

10% of Melanoma Survivors Report Intentional Tanning

Back to Top ▲